ADMA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.68

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

0.08

EPS Last/This Y

0.18

EPS This/Next Y

0.19

Price

9.88

Target Price

Analyst Recom

1.75

Performance Q

16.77

Upside

147.7%

Beta

0.79

Ticker: ADMA

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	ADMA	8.98	0.39	0.57	73005
2026-07-14	ADMA	8.86	0.39	11.77	73001
2026-07-15	ADMA	8.69	0.40	0.57	73413
2026-07-16	ADMA	8.81	0.40	0.82	73471
2026-07-17	ADMA	8.72	0.40	15.33	73495
2026-07-20	ADMA	8.76	0.32	0.22	67056
2026-07-21	ADMA	8.6	0.32	0.46	67477
2026-07-22	ADMA	8.38	0.32	0.20	67640
2026-07-23	ADMA	8.38	0.32	0.12	67690
2026-07-24	ADMA	8.28	0.32	0.02	67726
2026-07-27	ADMA	8.49	0.32	1.47	67808
2026-07-28	ADMA	8.78	0.32	0.20	68087
2026-07-29	ADMA	8.7	0.32	0.03	68109
2026-07-30	ADMA	8.68	0.32	0.00	68117
2026-07-31	ADMA	8.45	0.32	0.43	68131
2026-08-03	ADMA	8.74	0.32	0.02	68149
2026-08-04	ADMA	8.95	0.32	0.03	68541
2026-08-05	ADMA	9.29	0.31	0.12	69520
2026-08-07	ADMA	9.89	0.29	0.43	72470
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	ADMA	8.97	19.5	-	0.81
2026-07-14	ADMA	8.87	19.5	-	0.81
2026-07-15	ADMA	8.69	19.5	-	0.81
2026-07-16	ADMA	8.81	19.5	-	0.81
2026-07-17	ADMA	8.72	12.6	-	0.80
2026-07-20	ADMA	8.75	12.6	-	0.80
2026-07-21	ADMA	8.60	12.6	-	0.80
2026-07-22	ADMA	8.38	12.6	-	0.80
2026-07-23	ADMA	8.38	12.6	-	0.80
2026-07-24	ADMA	8.28	12.6	-	0.80
2026-07-27	ADMA	8.48	12.6	-	0.80
2026-07-28	ADMA	8.79	12.6	-	0.80
2026-07-29	ADMA	8.70	12.6	-	0.80
2026-07-30	ADMA	8.67	12.6	-	0.80
2026-07-31	ADMA	8.45	12.6	-	0.80
2026-08-03	ADMA	8.73	12.6	-	0.80
2026-08-04	ADMA	8.73	12.6	-	0.80
2026-08-05	ADMA	9.27	12.6	-	0.80
2026-08-06	ADMA	10.06	12.6	-	0.80
2026-08-07	ADMA	9.88	23.7	-	0.80
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	ADMA	-0.10	-4.75	10.76
2026-07-14	ADMA	-0.10	-4.75	10.76
2026-07-15	ADMA	-0.10	-4.75	10.76
2026-07-16	ADMA	-0.10	-4.75	10.76
2026-07-17	ADMA	-0.10	-4.75	10.76
2026-07-20	ADMA	-0.10	-5.37	10.76
2026-07-21	ADMA	-0.10	-5.37	10.76
2026-07-22	ADMA	-0.10	-5.37	10.76
2026-07-23	ADMA	-0.10	-5.37	10.76
2026-07-24	ADMA	-0.10	-5.37	10.76
2026-07-27	ADMA	-0.10	-5.78	10.67
2026-07-28	ADMA	-0.10	-5.78	10.67
2026-07-29	ADMA	-0.10	-5.78	10.67
2026-07-30	ADMA	-0.10	-5.78	10.67
2026-07-31	ADMA	-0.10	-5.78	10.67
2026-08-03	ADMA	-0.10	-5.85	10.68
2026-08-04	ADMA	-0.10	-5.85	10.68
2026-08-05	ADMA	-0.10	-5.85	10.68
2026-08-06	ADMA	-0.10	-5.85	10.68
2026-08-07	ADMA	-0.10	-5.85	10.68
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.16

Avg. EPS Est. Current Quarter

0.2

Avg. EPS Est. Next Quarter

0.24

Insider Transactions

-0.1

Institutional Transactions

-5.85

Beta

0.79

Average Sales Estimate Current Quarter

138

Average Sales Estimate Next Quarter

155

Fair Value

11.23

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

61.5

Max Drawdown 5-Year %

-69

Target Price

P/E

14.04

Forward P/E

10.49

PEG

0.47

P/S

4.32

P/B

5.46

P/Free Cash Flow

19.02

EPS

0.7

Average EPS Est. Cur. Y

0.8

EPS Next Y. (Est.)

0.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

32.98

Relative Volume

0.84

Return on Equity vs Sector %

14.1

Return on Equity vs Industry %

30.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

◆ ADMA Healthcare

$9.89

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

14/20

Pullback

8/25

Volume

7/15

Valuation

18/20

TP/AR

1/10

Options

8/10

RSI

68.2

Range 1M

78.7%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

16/30

Estimates

5/20

Inst/Vol

2/15

Options

8/10

EPS Yr

21.4%

EPS NY

18.3%

52W%

20.2%

💎

Long-Term Value

Quality companies, undervalued

STRONG

🟢 BUY +143.6% upside

Quality

30/30

Valuation

23/30

Growth

13/25

Stability

7/10

LT Trend

3/5

Upside

+143.6%

Quality

MoS

14%

ADMA — P/E HistoricalBiotechnology

ADMA Biologics Inc

Sector: Healthcare

Industry: Biotechnology

Employees: 640

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

ADMA

Latest News

—

Caricamento notizie per ADMA…

stock quote shares ADMA – Adma Biologics Inc Stock Price stock today

news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ADMA – Adma Biologics Inc yahoo finance google finance

stock history ADMA – Adma Biologics Inc invest stock market

stock prices ADMA premarket after hours

ticker ADMA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ADMA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y